✦ LIBER ✦

PDG16: BUDGETARY IMPACT OF TREATMENT GUIDELINES—THE EXAMPLE OF TYPE 2 DIABETES

✍ Scribed by O Pirk; A Goertz; A Spannheimer; U Reitberger; A Liebl

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB74 TREATMENT OF TYPE 2 DIABETES VS. C

✍ K Tempas; M Skovira; P Kohli; Y Wu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PDG10: A PHARMACOECONOMIC MODEL OF HbA1c

✍ H Lilliu; J Bonastre; L Cabrieres 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

PDG5: MODELING THE IMPACT OF A NEW ORAL

✍ C Brun-Strang; J Caro; L Annemans; J O'Brien; F Everhard; J Grueger 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

The impact of new insights and revised p

✍ René Lub; Petra Denig; Paul B. Van Den Berg; Klaas Hoogenberg; Lolkje T. W. De J 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

PDB62 The Impact of Clinical Inertia in

✍ McEwan, P.; Prettyjohns, M.; Ketsetzis, G.; Evans, L.M.; Bergenheim, K. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PDG1: THE OUTCOMES OF LONG-TERM TREATMEN

✍ N Maniadakis; A Kielhorn; K Heikkinen; A Brandt; R Jansen 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB